Article
Mitochondrial hyperactivity as a potential therapeutic target in Parkinson’s disease
1 Jan 2020
Abstract excerpt
Mitochondrial dysfunction is thought to contribute to neurodegeneration in Parkinson's disease (PD), yet the cellular events that lead to mitochondrial disruption remain unclear. Post-mortem studies of PD patient brains and the use of complex I inhibitors to model the disease previously suggested a reduction in mitochondrial activity as a causative factor in PD, but this may represent an endpoint in the disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
